161
CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
Condition(s):HealthyLast Updated:March 10, 2015Completed
ATORVASTATIN CALCIUM: 1085 Clinical Trials, Page 17 of 109
Hide Studies Not Open or Pending
162
Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)
Condition(s):HypercholesterolemiaLast Updated:February 17, 2022Completed
163
Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
Condition(s):HypercholesterolemiaLast Updated:February 22, 2022Completed
164
Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Condition(s):Cardiovascular Diseases; Arthritis, RheumatoidLast Updated:August 14, 2019Completed
165
Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis
Condition(s):PsoriasisLast Updated:November 23, 2015Completed
166
Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers
Condition(s):Hypertension With HyperlipidemiaLast Updated:March 12, 2018Completed
167
Optimalization of Nephroprotection Using Atorvastatin (Sortis)
Condition(s):Chronic Kidney Disease; ProteinuriaLast Updated:December 13, 2007Completed
168
Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Condition(s):HypercholesterolemiaLast Updated:February 23, 2018Completed
169
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition(s):Autosomal Dominant Polycystic Kidney Disease; Chronic Kidney DiseasesLast Updated:May 23, 2023Enrolling by invitation
170
Single Dose of Atorvastatin and Circulating Endothelial Microparticles
Condition(s):Endothelium; Hydroxymethylglutaryl-CoA Reductase InhibitorsLast Updated:May 15, 2014Unknown status